Mirum Pharmaceuticals (MIRM) Other Operating Expenses (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Other Operating Expenses of $755.1 million for Q1 2026, up 2595.08% year-over-year from $28.0 million in Q1 2025, and up 2571.62% quarter-over-quarter from $28.3 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Other Operating Expenses (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $755.1 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 2595.08% year-over-year to $755.1 million; the TTM figure through Mar 2026 stood at $832.3 million (up 806.37% YoY), while the FY2025 annual figure was $100.2 million, up 22.78% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $755.1 million, up from $28.3 million in the prior quarter.
- The five-year high for Other Operating Expenses was $755.1 million in Q1 2026, with the low at $2.4 million in Q1 2022.
- The 5-year median for Other Operating Expenses is $20.2 million (2024), against an average of $58.9 million.
- The sharpest annual moves came in 2024 and 2026: Other Operating Expenses declined 8.95% in 2024, then soared 2595.08% in 2026.
- Mirum Pharmaceuticals' Other Operating Expenses stood at $4.5 million in 2022, then jumped by 456.74% to $25.0 million in 2023, then declined by 8.95% to $22.8 million in 2024, then rose by 24.07% to $28.3 million in 2025, then soared by 2571.62% to $755.1 million in 2026.
- Business Quant data shows MIRM's Other Operating Expenses at $755.1 million in Q1 2026, $28.3 million in Q4 2025, and $25.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.78 Mn |
| Mar 31, 2026 | 755.11 Mn |
| Dec 31, 2025 | 28.26 Mn |
| Sep 30, 2025 | 25.54 Mn |
| Jun 30, 2025 | 23.42 Mn |
| Mar 31, 2025 | 28.02 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 20.81 Mn |
| Jun 30, 2024 | 20.23 Mn |
| Mar 31, 2024 | 17.83 Mn |
| Dec 31, 2023 | 25.02 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 4.49 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 1.90 Mn |